[go: up one dir, main page]

DZ2854A1 - Dérivés de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation. - Google Patents

Dérivés de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation.

Info

Publication number
DZ2854A1
DZ2854A1 DZ990154A DZ990154A DZ2854A1 DZ 2854 A1 DZ2854 A1 DZ 2854A1 DZ 990154 A DZ990154 A DZ 990154A DZ 990154 A DZ990154 A DZ 990154A DZ 2854 A1 DZ2854 A1 DZ 2854A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical compositions
compositions containing
thiazolidinedione derivatives
thiazolidinedione
derivatives
Prior art date
Application number
DZ990154A
Other languages
English (en)
French (fr)
Inventor
Antoine Michel Alain Bril
Robin Edwin Buckingham
Nassirah Khandoudi
Original Assignee
Smithkline Beecham Lab
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9815871.0A external-priority patent/GB9815871D0/en
Priority claimed from GBGB9815872.8A external-priority patent/GB9815872D0/en
Application filed by Smithkline Beecham Lab, Smithkline Beecham Plc filed Critical Smithkline Beecham Lab
Application granted granted Critical
Publication of DZ2854A1 publication Critical patent/DZ2854A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DZ990154A 1998-07-21 1999-07-21 Dérivés de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation. DZ2854A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9815871.0A GB9815871D0 (en) 1998-07-21 1998-07-21 Novel compound
GBGB9815872.8A GB9815872D0 (en) 1998-07-21 1998-07-21 Novel method

Publications (1)

Publication Number Publication Date
DZ2854A1 true DZ2854A1 (fr) 2003-12-01

Family

ID=26314086

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990154A DZ2854A1 (fr) 1998-07-21 1999-07-21 Dérivés de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation.

Country Status (35)

Country Link
EP (2) EP1098638B1 (cs)
JP (1) JP2002521325A (cs)
KR (1) KR20010079550A (cs)
CN (1) CN1167416C (cs)
AP (1) AP1416A (cs)
AR (1) AR020614A1 (cs)
AT (1) ATE318588T1 (cs)
AU (1) AU5053599A (cs)
BG (1) BG105251A (cs)
BR (1) BR9912144A (cs)
CA (1) CA2338216A1 (cs)
CO (1) CO5060465A1 (cs)
CY (1) CY1106078T1 (cs)
CZ (1) CZ2001250A3 (cs)
DE (1) DE69930125T2 (cs)
DK (1) DK1098638T3 (cs)
DZ (1) DZ2854A1 (cs)
EA (1) EA004772B1 (cs)
ES (1) ES2259839T3 (cs)
GC (1) GC0000173A (cs)
HU (1) HUP0103870A3 (cs)
ID (1) ID27850A (cs)
IL (1) IL140741A0 (cs)
MA (1) MA26662A1 (cs)
NO (1) NO20010293L (cs)
NZ (1) NZ509175A (cs)
OA (1) OA11583A (cs)
PE (1) PE20000881A1 (cs)
PL (1) PL345663A1 (cs)
PT (1) PT1098638E (cs)
SI (1) SI1098638T1 (cs)
SK (1) SK1022001A3 (cs)
TR (1) TR200100208T2 (cs)
TW (2) TWI239836B (cs)
WO (1) WO2000004889A1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7073400A (en) 1999-08-27 2001-03-26 Eli Lilly And Company Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
AP2002002688A0 (en) * 2000-06-16 2002-12-31 Smithkline Beecham Plc Treatment and prevention of cardiac insulin resistance associated associated conditions.
WO2003009807A2 (en) 2001-07-23 2003-02-06 Galileo Laboratories, Inc. Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
JPH05202042A (ja) * 1992-01-24 1993-08-10 Sankyo Co Ltd 糖尿病性合併症治療剤
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9611947D0 (en) * 1996-06-07 1996-08-07 Glaxo Group Ltd Medicaments
US6277819B1 (en) * 1996-08-30 2001-08-21 Eli Lilly And Company Use of GLP-1 or analogs in treatment of myocardial infarction
CN1235543A (zh) * 1996-09-12 1999-11-17 三共株式会社 含有曲格列酮的谷胱甘肽还原酶活性增强剂
AU1172999A (en) * 1997-11-19 1999-06-07 Takeda Chemical Industries Ltd. Novel apoptosis inhibitors
WO1999043326A1 (en) * 1998-02-24 1999-09-02 The Trustees Of The University Of Pennsylvania Use of a cardiac purinoceptor to effect cellular glucose uptake
AU4005299A (en) * 1998-05-19 1999-12-06 Regents Of The University Of California, The Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis
US5968960A (en) * 1999-01-14 1999-10-19 The Regents Of The University Of California Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism

Also Published As

Publication number Publication date
SI1098638T1 (sl) 2006-06-30
OA11583A (en) 2004-07-01
BG105251A (en) 2001-10-31
JP2002521325A (ja) 2002-07-16
IL140741A0 (en) 2002-02-10
KR20010079550A (ko) 2001-08-22
ES2259839T3 (es) 2006-10-16
CN1167416C (zh) 2004-09-22
NO20010293D0 (no) 2001-01-18
ID27850A (id) 2001-04-26
PL345663A1 (en) 2002-01-02
EP1098638B1 (en) 2006-03-01
NO20010293L (no) 2001-03-07
AU5053599A (en) 2000-02-14
AP1416A (en) 2005-06-13
EP1523980A3 (en) 2009-03-18
DK1098638T3 (da) 2006-06-19
PT1098638E (pt) 2006-07-31
EP1523980A2 (en) 2005-04-20
CA2338216A1 (en) 2000-02-03
SK1022001A3 (en) 2001-08-06
TW200307532A (en) 2003-12-16
AP2001002033A0 (en) 2001-03-31
NZ509175A (en) 2003-10-31
CZ2001250A3 (cs) 2002-03-13
EA200100164A1 (ru) 2001-08-27
AR020614A1 (es) 2002-05-22
HUP0103870A3 (en) 2003-06-30
CO5060465A1 (es) 2001-07-30
PE20000881A1 (es) 2000-10-07
HUP0103870A2 (hu) 2002-05-29
WO2000004889A1 (en) 2000-02-03
DE69930125T2 (de) 2006-10-05
DE69930125D1 (de) 2006-04-27
TWI239836B (en) 2005-09-21
GC0000173A (en) 2006-03-29
CN1310619A (zh) 2001-08-29
TR200100208T2 (tr) 2001-05-21
EA004772B1 (ru) 2004-08-26
EP1098638A1 (en) 2001-05-16
CY1106078T1 (el) 2011-06-08
ATE318588T1 (de) 2006-03-15
BR9912144A (pt) 2001-04-03
MA26662A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
DZ2594A1 (fr) Dérivés de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
FR2708608B1 (fr) Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
FR2732967B1 (fr) 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
DZ3191A1 (fr) Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
FR2708606B1 (fr) Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
DZ2979A1 (fr) Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant.
DZ2614A1 (fr) Compositions pharmaceutiques topiques contenant des dérivés de résorcinol.
MA26491A1 (fr) Composes inhibiteurs selectifs de cox-2, anti-inflammatoires et compositions pharmaceutiques les contenant .
MA26472A1 (fr) Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
DZ2361A1 (fr) Dérivés de 6-phénylpyridyl-2-amine et compositionspharmaceutiques les contenant
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
DZ1916A1 (fr) Composés nouveaux et compostions pharmaceutiques les contenant.
MA26490A1 (fr) Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.
MA26443A1 (fr) Aralkyl- et aralkylidene-lactames et -imides heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
DZ2978A1 (fr) Composés chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
MA26559A1 (fr) Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
EE03692B1 (et) 19-nor-pregneeni derivaadid, mis omavad progestaatilist toimet ja neid sisaldavad farmatseutilised kompositsioonid
DZ2188A1 (fr) Dérivés de quinoxalinedone, procédés et intermédiaires pour leur préparation et compositions pharmaceutiques les contenant.
ATE222897T1 (de) Substituierte thiazolidinedione derivate, ihre herstellung und pharmazeutische zusammensetzungen,die sie enthalten
FR2681067B1 (fr) Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.